Trim LMT 20-25% to 75-80% weight, redeploy to Treasuries, hedge with put spread
This is a TIMING call against an intact QUALITY franchise. The 10/07 binding reflection validates 20-25% trim as the calibrated sweet spot (yielded +2.2% alpha last round); the 10/02 binding reflection caps trim magnitude below the trader's 30-50% proposal; the 8/13 binding reflection prohibits magnitude-overshoot to full Sell. The disciplined path is Underweight at 75-80% of benchmark weight, trimmed 20-25% at market, hedged with defined-risk put spread, capital redeployed to capture the -180bps yield gap, hard stop at $490, and re-engagement gated on $519.79 technical reclaim or clean Q3 earnings delivery.
| Position | Action |
|---|---|
| Market open next session | Trim 20-25% of LMT position at market |
| Post-trim residual | Target 75-80% of benchmark weight |
| ~1.5-2% of residual notional | Buy $500/$480 put spread Nov cycle for defined tail-risk hedge into Q3 earnings |
| Trim proceeds | Redeploy to 3-month or 6-month T-bills at ~4.5% yield |
| Residual position close below $490 on any session | Hard stop - structural invalidation of Underweight thesis |
Record Q2 2026 fundamentals (revenue $20.06B, EPS $7.94, net income $1.836B up 437% YoY) at a 15.5x forward P/E with PEG of 0.94 are diverging violently from bearish technical price action, creating a mispricing opportunity with a 2.76% dividend yield providing income while waiting for re-rating.
| Indicator | Value | Signal |
|---|---|---|
| Close | 507.89 | bearish |
| 10 EMA | 510.36 | bearish |
| 50 SMA | 548.72 | bearish |
| 200 SMA | 557.74 | bearish |
| MACD | -11.08 | bearish |
| MACD Signal | -10.70 | bearish |
| MACD Histogram | -0.38 | neutral |
| RSI(14) | 38.55 | neutral |
| Bollinger Upper Band | 544.18 | bearish |
| Bollinger Middle Band | 519.79 | bearish |
| Bollinger Lower Band |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Operating margin ≥12.0% AND FCF ≥$1.5B AND buyback resumption authorization (8-K filing)
Then: Upgrade to Hold; close put spread and reassess LMT positioning
LMT holds monopoly-like prime contractor positions on irreplaceable defense programs with decades-long lifecycles
↩ rebuts: “Bear's framing of LMT as merely exposed to government budget cycles rather than an oligopoly position”
EV: +11% (excluding dividend) · concedes: The tape is unambiguously weak with price below all moving averages; MACD deeply negative at -11.08; A single counter-trend signal failed (Sep 21 positive cross); The market needs 4-12 weeks to re-rate after record fundamental data; Not arguing for blind all-in entry today — position sizing and stops are appropriate
LMT at $507 is not a buying opportunity but a falling knife—the market has had 60+ trading days to re-rate record fundamentals and chosen to sell instead; the stock requires multiple positive catalysts (no program shocks, geopolitical premium holds, technical breakout above $519.79) while facing single-point-of-failure risks from Sentinel restructuring, Ukraine negotiations, and DoD diversification away from legacy primes.
EV: ~+1% total return over 12 months (including 2.76% dividend) · concedes: 24/7 political support for defense budgets provides some fundamental floor; Monopoly positioning remains nominally dominant at the core; Dividend provides income, though not a floor against capital loss; Backlog provides revenue visibility, even if concentrated; Technical coiling could resolve upward if macro catalyzes it
→ vs neutral: Record Q2 earnings (+437% growth) are base-effect noise from restructuring charges, not fundamental breakthrough—the 8.6% selloff on the print was the market's verdict rejecting the thesis
| 495.40 |
| neutral |
| ATR(14) | 11.04 | neutral |
Support: 495.4 · 488.62 · 470 | Resistance: 510.36 · 519.79 · 548.72
The technical profile for LMT is firmly bearish: price is below all three moving averages (10 EMA, 50 SMA, 200 SMA), the 50 SMA is rolling over, and the MACD line remains deeply negative at –11.08. The MACD histogram contraction to –0.38 and ATR compression to 11.04 (down 31% from peak) suggest downside momentum is decelerating and volatility is coiling—a potential base-building phase that has NOT been confirmed. The RSI at 38.55 is approaching but not yet deeply oversold, and a prior bullish divergence signal on Sep 21 failed. Resistance is identified at 510.36 (10 EMA), 519.79 (20 SMA/Bollinger middle), and 548.72 (50 SMA), while support lies at 495.40 (Bollinger lower band tested Oct 7), 488.62 (June 24 swing low), and ~470 (March/April breakdown area). No trade trigger has been met; a confirmed bottoming sequence would require a close above 510 on rising volume, followed by a higher low and close above 519.79 with RSI recovering above 45 and MACD histogram turning positive for 2+ sessions.
Market Cap
$117.2B
Shares Outstanding
~230 million diluted
Current Implied Price
~$510
Beta
0.095
Dividend Yield
2.76%
P/E (TTM)
18.72x
Forward P/E
15.54x
Forward EPS
$32.69
PEG Ratio
0.94
Price/Book
13.32x
EV/EBITDA (TTM)
~12.2x
FCF Yield (TTM)
~4.7%
Revenue FY2025
$75.05B
Revenue FY2024
$71.04B
Revenue FY2023
$67.57B
Revenue FY2021
$65.98B
Revenue CAGR (2021-2025)
~3.3%
Revenue TTM
$77.0B
Gross Profit FY2025
$7.62B
Operating Income FY2025
$7.73B
EBITDA FY2025
$8.73B
EBITDA FY2024
$8.82B
EBITDA FY2023
$10.44B
Net Income FY2025
$5.02B
Net Income FY2024
$5.34B
Net Income FY2023
$6.92B
Net Income TTM
$6.29B
Diluted EPS FY2025
$21.49
Diluted EPS FY2024
$22.31
Diluted EPS FY2023
$27.55
Diluted EPS TTM
$27.13
Operating Margin
12.0%
Gross Margin
11.8%
Net Margin
8.16%
Effective Tax Rate
~15.3%
Q2 2026 Revenue
$20.06B
Q2 2026 Net Income
$1.836B
Q2 2026 EPS
$7.94
Q2 2026 EBITDA
$2.84B
Q2 2025 Revenue
$18.16B
Q2 2025 Net Income
$342M
Q2 2025 EPS
$1.46
Q2 2026 vs Q2 2025 Revenue Growth
+10.5%
Q2 2026 vs Q2 2025 Net Income Growth
+437%
Q2 2026 vs Q2 2025 EPS Growth
+444%
Total Assets Q2 2026
$62.45B
Total Liabilities Q2 2026
$53.68B
Stockholders' Equity Q2 2026
$8.77B
Total Debt Q2 2026
$20.54B
Net Debt Q2 2026
$16.75B
Cash & Equivalents Q2 2026
$3.79B
Receivables Q2 2026
$19.39B
Inventory Q2 2026
$4.41B
Current Deferred Revenue Q2 2026
$12.15B
Current Ratio Q2 2026
1.19
Pension/OPEB Liability Q2 2026
$3.93B
FCF FY2025
$6.91B
OCF FY2025
$8.56B
Capex FY2025
$1.65B
FCF/Revenue FY2025
9.2%
FCF Conversion (FCF/Net Income) FY2025
138%
Dividends Paid FY2025
$3.13B
Buybacks FY2025
$3.00B
Annual Dividend Per Share
~$3.30
50-Day Moving Average
$551.59
200-Day Moving Average
$563.36
52-Week High
$692
52-Week Low
$437.25
ROE
89.2%
ROA
8.6%
S&P Credit Rating
A / A−
Strengths
Concerns
Lockheed Martin delivered record Q2 2026 results with all-time high revenue of $20.06B, EPS of $7.94, and net income of $1.84B, representing a dramatic turnaround from the prior year's charge-induced trough; forward consensus expects ~21% EPS growth to $32.69 with a PEG ratio of 0.94 and 15.54x forward P/E suggesting modest undervaluation. The company is generating all-time high free cash flow ($6.91B in FY2025 with 138% conversion), has reduced share count by 13% through buybacks, maintains a deleveraging balance sheet (net debt declined to $16.75B), and carries an all-time high backlog of $12.15B in deferred revenue. Despite these improving fundamentals, the stock trades ~10% below its 200-day moving average, presenting a potential mean-reversion opportunity, though risks include CR-driven budget uncertainty, program-specific cost overruns, and geopolitical sensitivity.
Macro: Benign macro overlay for LMT: Fed is locked on hold with 96% priced probability of zero cuts in 2026 (6+ cuts at 0–0.4%); U.S. recession probability at 6% (-2.0pp week-over-week) supporting continued FY2026/FY2027 procurement budget passage; oil stable at ~$103/bbl despite Iran tensions de-escalating (mildly disinflationary, no oil-driven inflation surprise); mortgage rates near 3-year highs confirming higher-for-longer rate regime (positive for pension/discount-rate sensitivity vs. 2022–2023). FRED data unavailable for 10Y Treasury yield, VIX, and headline CPI. Polymarket pricing a no-cut, no-recession, no-shutdown steady-state into late 2026.